Detalhe da pesquisa
1.
Exome sequencing study in patients with multiple sclerosis reveals variants associated with disease course.
J Neuroinflammation
; 15(1): 265, 2018 Sep 14.
Artigo
Inglês
| MEDLINE | ID: mdl-30217166
2.
Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.
Brain
; 138(Pt 4): 918-31, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25688078
3.
Identification of patients with relapsing multiple sclerosis eligible for high-efficacy therapies.
Neurodegener Dis Manag
; 11(3): 251-261, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33966475
4.
CSF Chitinase 3-Like 2 Is Associated With Long-term Disability Progression in Patients With Progressive Multiple Sclerosis.
Neurol Neuroimmunol Neuroinflamm
; 8(6)2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34497102
5.
The Multiple Sclerosis Data Alliance Catalogue: Enabling Web-Based Discovery of Metadata from Real-World Multiple Sclerosis Data Sources.
Int J MS Care
; 23(6): 261-268, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-35035297
6.
Tolerability and safety of dimethyl fumarate in relapsing multiple sclerosis: a prospective observational multicenter study in a real-life Spanish population.
J Neurol
; 267(8): 2362-2371, 2020 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-32350647
7.
Selective induction of cAMP phosphodiesterase PDE4B2 expression in experimental autoimmune encephalomyelitis.
J Neuropathol Exp Neurol
; 66(10): 923-31, 2007 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-17917586
8.
Pharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN-ß.
Neurol Neuroimmunol Neuroinflamm
; 2(5): e154, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26445728